AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Misguided Alzheimer Advances
This chapter explores the detrimental effects of faulty research in Alzheimer's studies, particularly focusing on the misinterpretation of amyloid beta protein's role in the disease. It critiques the approval of the Likimbi drug amid scientific skepticism and highlights the need for cautious evaluation of drug efficacy versus side effects.